新兴的、演变的和已确立的传染病及干预措施。
Emerging, evolving, and established infectious diseases and interventions.
机构信息
Center for Statistics and Quantitative Infectious Diseases, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA. Department of Biostatistics, University of Washington, Seattle, WA 98105, USA.
Center for Statistics and Quantitative Infectious Diseases, Department of Biostatistics, College of Public Health and Health Professions, and College of Medicine, University of Florida, Gainesville, FL 32611, USA.
出版信息
Science. 2014 Sep 12;345(6202):1292-4. doi: 10.1126/science.1254166.
Abstract
Planning, implementing, and evaluating interventions against infectious diseases depend on the nature of the infectious disease; the availability of intervention measures; and logistical, economic, and political constraints. Infectious diseases and vaccine- or drug-based interventions can be loosely categorized by the degree to which the infectious disease and the intervention are well established. Pertussis, polio, and measles are three examples of long-known infectious diseases for which global vaccination has dramatically reduced the public health burden. Pertussis vaccination was introduced in the 1940s, polio vaccination in the 1950s, and measles vaccination in the 1960s, nearly eliminating these diseases in many places.
摘要
规划、实施和评估传染病干预措施取决于传染病的性质、干预措施的可及性以及后勤、经济和政治方面的限制。传染病和疫苗或药物干预措施可以根据传染病和干预措施的成熟程度进行粗略分类。百日咳、脊髓灰质炎和麻疹是三种众所周知的传染病，全球疫苗接种显著降低了这些疾病的公共卫生负担。百日咳疫苗于 20 世纪 40 年代推出，脊髓灰质炎疫苗于 20 世纪 50 年代推出，麻疹疫苗于 20 世纪 60 年代推出，几乎在许多地方消除了这些疾病。
相似文献
1
Emerging, evolving, and established infectious diseases and interventions.新兴的、演变的和已确立的传染病及干预措施。
Science. 2014 Sep 12;345(6202):1292-4. doi: 10.1126/science.1254166.
2
The re-emergency and persistence of vaccine preventable diseases.疫苗可预防疾病的再度出现和持续存在。
An Acad Bras Cienc. 2015 Aug;87(2 Suppl):1311-22. doi: 10.1590/0001-3765201520140663. Epub 2015 Aug 25.
3
Major factors affecting the emergence and re-emergence of infectious diseases.影响传染病出现和再次出现的主要因素。
Clin Lab Med. 2004 Sep;24(3):559-86, v. doi: 10.1016/j.cll.2004.05.008.
4
Eradication of infectious diseases: its concept, then and now.传染病的根除：其概念，过去与现在。
Jpn J Infect Dis. 2004 Feb;57(1):1-6.
5
Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles-rubella vaccine among Forcibly Displaced Myanmar Nationals in Bangladesh.孟加拉国境内被迫流离失所的缅甸国民中口服霍乱疫苗、口服脊髓灰质炎疫苗和麻疹风疹疫苗接种后运动覆盖情况评估。
Hum Vaccin Immunother. 2019;15(12):2882-2886. doi: 10.1080/21645515.2019.1616502. Epub 2019 Aug 23.
6
Infectious diseases threaten refugees entering Pakistan.传染病威胁着进入巴基斯坦的难民。
Lancet Infect Dis. 2001 Nov;1(4):214. doi: 10.1016/S1473-3099(01)00102-5.
7
Burden of vaccine preventable diseases at large events.大型活动中疫苗可预防疾病的负担。
Vaccine. 2015 Nov 27;33(48):6552-63. doi: 10.1016/j.vaccine.2015.09.076. Epub 2015 Oct 4.
8
Eradication, elimination, and control: which disease next?根除、消除与控制：下一个是哪种疾病？
Rev Infect Dis. 1982 Sep-Oct;4(5):966-71. doi: 10.1093/clinids/4.5.966.
9
The book reopened on infectious diseases.关于传染病的这本书重新翻开了。
Microbes Infect. 2008 Jul;10(9):942-7. doi: 10.1016/j.micinf.2008.07.012. Epub 2008 Jul 10.
10
[New and newly reappearing infectious diseases--the moving goal of infection epidemiology].[新发和新再现传染病——感染性疾病流行病学不断变化的目标]
Duodecim. 2002;118(19):2027-30.
引用本文的文献
1
Nanoscale hyperthermia mesostructures for sustainable antimicrobial design.用于可持续抗菌设计的纳米级热疗介观结构
Cell Rep Phys Sci. 2024 Jul 17;5(7). doi: 10.1016/j.xcrp.2024.102081. Epub 2024 Jul 8.
2
Travelling with a parasite: the evolution of resistance and dispersal syndromes during experimental range expansion.带着寄生虫旅行：实验性分布范围扩展过程中抗性和扩散综合征的进化。
Proc Biol Sci. 2023 Jan 11;290(1990):20221966. doi: 10.1098/rspb.2022.1966. Epub 2023 Jan 4.
3
Application of logistic differential equation models for early warning of infectious diseases in Jilin Province.基于逻辑斯蒂差分方程模型的吉林省传染病早期预警应用。
BMC Public Health. 2022 Nov 4;22(1):2019. doi: 10.1186/s12889-022-14407-y.
4
Universal Health Coverage to counteract the economic impact of the COVID-19 infection: current practices and ethical challenges.全民健康覆盖以应对 COVID-19 感染的经济影响：当前做法和伦理挑战。
J Prev Med Hyg. 2021 Jan 14;61(4):E520-E524. doi: 10.15167/2421-4248/jpmh2020.61.4.1581. eCollection 2020 Dec.
5
Investigation on the Occurrence of Species in Borderline of Iran and Azerbaijan for Control of Arboviral Diseases.伊朗与阿塞拜疆边境地区虫媒病毒病防控相关物种的发生情况调查
J Arthropod Borne Dis. 2019 Jun 24;13(2):191-197. eCollection 2019 Jun.
6
Daylight-driven rechargeable antibacterial and antiviral nanofibrous membranes for bioprotective applications.用于生物防护应用的日光驱动可充电抗菌抗病毒纳米纤维膜。
Sci Adv. 2018 Mar 16;4(3):eaar5931. doi: 10.1126/sciadv.aar5931. eCollection 2018 Mar.
7
The Driving Force for 2014 Dengue Outbreak in Guangdong, China.2014年中国广东登革热疫情的驱动因素
PLoS One. 2016 Nov 18;11(11):e0166211. doi: 10.1371/journal.pone.0166211. eCollection 2016.
8
Impact of human mobility on the emergence of dengue epidemics in Pakistan.人类流动对巴基斯坦登革热疫情出现的影响。
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11887-92. doi: 10.1073/pnas.1504964112. Epub 2015 Sep 8.
本文引用的文献
1
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.新型四价登革热疫苗在亚洲健康儿童中的临床疗效和安全性：一项 3 期、随机、观察者设盲、安慰剂对照试验。
Lancet. 2014 Oct 11;384(9951):1358-65. doi: 10.1016/S0140-6736(14)61060-6. Epub 2014 Jul 10.
2
Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013.2013 年以色列野生脊髓灰质炎 1 型病毒静悄悄地引入和持续传播的分子流行病学研究
Euro Surveill. 2014 Feb 20;19(7):20709. doi: 10.2807/1560-7917.es2014.19.7.20709.
3
Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.美国百日咳杆菌中缺乏丝状血凝素的百日咳博德特氏菌的流行情况及分子特征
Clin Vaccine Immunol. 2014 Feb;21(2):119-25. doi: 10.1128/CVI.00717-13. Epub 2013 Nov 20.
4
Insidious reintroduction of wild poliovirus into Israel, 2013.2013 年野生脊髓灰质炎病毒在以色列的悄然再现。
Euro Surveill. 2013 Sep 19;18(38):20586. doi: 10.2807/1560-7917.es2013.18.38.20586.
5
Waning immunity to pertussis following 5 doses of DTaP.五剂 DTaP 后百日咳的免疫效力下降。
Pediatrics. 2013 Apr;131(4):e1047-52. doi: 10.1542/peds.2012-1928. Epub 2013 Mar 11.
6
Perplexities of pertussis: recent global epidemiological trends and their potential causes.百日咳的困惑：近期全球流行病学趋势及其潜在原因。
Epidemiol Infect. 2014 Apr;142(4):672-84. doi: 10.1017/S0950268812003093. Epub 2013 Jan 16.
7
Urban cholera transmission hotspots and their implications for reactive vaccination: evidence from Bissau city, Guinea bissau.城市霍乱传播热点及其对反应性疫苗接种的影响：来自几内亚比绍比绍市的证据。
PLoS Negl Trop Dis. 2012;6(11):e1901. doi: 10.1371/journal.pntd.0001901. Epub 2012 Nov 8.
8
WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011.世界卫生组织推荐用于 2012 年南半球流感疫苗的病毒：2011 年 2 月至 9 月采集的甲型 H1N1pdm09、甲型 H3N2 和乙型流感病毒的流行病学、抗原性和遗传学特征。
Vaccine. 2012 Oct 5;30(45):6461-71. doi: 10.1016/j.vaccine.2012.07.089. Epub 2012 Aug 20.
9
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.RTS,S/AS01 疟疾疫苗在非洲儿童中进行的 3 期临床试验的初步结果。
N Engl J Med. 2011 Nov 17;365(20):1863-75. doi: 10.1056/NEJMoa1102287. Epub 2011 Oct 18.
10
Vaccination strategies for epidemic cholera in Haiti with implications for the developing world.海地流行性霍乱的疫苗接种策略及其对发展中国家的影响。
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7081-5. doi: 10.1073/pnas.1102149108. Epub 2011 Apr 11.
Zotero 插件